Fulcrum Therapeutics, Inc. Investigation: Learn More Now Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. (“Fulcrum Therapeutics” or the “Company”) (NASDAQ: FULC)…. Read MoreJoin Investigation
Veritone, Inc. Class Action Alert: Learn More Now Kaplan Fox Alerts Investors of Veritone, Inc. (NASDAQ: VERI) to a Securities Class Action Deadline on July 20, 2026… Read MoreJoin Investigation
Regencell Bioscience Holdings. Shareholder Alert: Learn More Now Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case… Read MoreJoin Investigation
ImmunityBio, Inc. Class Action Alert: Learn More Now Kaplan Fox Alerts Investors of ImmunityBio, Inc. (IBRX) to a Securities Class Action Deadline on May 26, 2026… Read MoreJoin Investigation
Soleno Therapeutics Shareholder Alert: Learn More Now Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026… Read MoreJoin Investigation
Eos Energy Enterprises Shareholder Alert: Learn More Now Kaplan Fox Encourages Investors of Eos Energy Enterprises (EOSE) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026… Read MoreJoin Investigation
Oddity Tech Ltd. Shareholder Alert: Learn More Now Kaplan Fox is Investigating Oddity Tech Ltd. (ODD) for Potential Securities Law Violations… Read MoreJoin Investigation
Grail, Inc. Shareholder Alert: Learn More Now GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law Violations… Read MoreJoin Investigation